Clinical Trial

Use of QRX3 for Acute Tubular Necrosis Type of Renal Failure in Hospitalized Patients ( QRX-3 in ARF)

Name: Use of QRX3 for Acute Tubular Necrosis Type of Renal Failure in Hospitalized Patients ( QRX-3 in ARF) — clinical trial record (NCT07161843)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: QRX3 in ARF

Not Yet Recruiting Phase 2/3

View on ClinicalTrials.gov →

Summary

Use of QRX-3 in hospitalized patients with pediatric and adult patients with acute tubular necrosis renal failure

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-09-03.

Trial Details

NCT Number	NCT07161843
Lead Sponsor	Ebima Clifford Okundaye
Conditions	Acute Renal Failure (ARF), Acute Tubular Necrosis
Enrollment	500 participants
Start Date	2026-06-30
Primary Completion	2026-12-30 (estimated)
Study Completion	2027-02-01 (estimated)
Updated on ClinicalTrials.gov	2026-02-18